Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 7,347 shares, an increase of 826.5% from the October 15th total of 793 shares. Based on an average daily volume of 44,458 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the company’s shares are sold short.
Raia Drogasil Stock Performance
Shares of OTCMKTS:RADLY opened at $2.56 on Friday. The firm has a 50 day moving average of $3.57 and a 200 day moving average of $4.00. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $3.37 billion and a price-to-earnings ratio of 14.86. Raia Drogasil has a 52 week low of $2.56 and a 52 week high of $5.34.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 20.61% and a net margin of 2.89%. The business had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $2.43 billion. On average, sell-side analysts predict that Raia Drogasil will post 0.17 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a “buy” rating and set a $5.20 target price for the company in a report on Sunday, October 18th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $5.20.
Check Out Our Latest Analysis on Raia Drogasil
About Raia Drogasil
Raia Drogasil, now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands. The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery. In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms.
Further Reading
- Five stocks we like better than Raia Drogasil
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
